Article | September 23, 2021

Scheduling Aseptic Filling For Preclinical And Clinical Batches


A biopharmaceutical sponsor’s selection of a CDMO partner is a matter of finding the appropriate partner for a particular job. While a prospective partner’s qualifications may appear acceptable on paper, its company culture, the priority it places on a client’s project, or its availability to schedule client aseptic filling runs may not make it a good fit.

Drug Development and Project Scheduling Challenges

Operating in the drug development space — primarily for small-batch aseptic manufacturing for preclinical and clinical use — Singota is keenly aware of the project scheduling challenges faced by our clients. We have built our business with the understanding that many factors affect drug development timelines, from the intricacies of cutting-edge chemistry to the unpredictable-at-times availability of raw materials, that are often beyond our clients’ control.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma